China has seized on geopolitical turmoil to present itself as stable and business friendly, according to one of the world’s largest drugmakers, as the industry grapples with potential US tariffs and uncertainty about healthcare policy.
Novartis chief executive Vas Narasimhan recently attended the China Development Forum, often called China’s Davos, alongside dozens of business leaders in industries from finance to energy.
“Given the global geopolitical environment, [China is] seeing an opportunity to be very business friendly and stable,” he told the Financial Times, adding that the country was “very open to multinationals”.
您已閱讀18%（631字），剩餘82%（2946字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。